发表状态 | 已发表Published |
题名 | Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real-world study |
作者 | |
发表日期 | 2024-08-01 |
发表期刊 | CNS Neuroscience and Therapeutics
![]() |
ISSN/eISSN | 1755-5930 |
卷号 | 30期号:8 |
摘要 | Aims: To evaluate the efficacy, safety, and tolerability of adjunctive lacosamide therapy against focal seizures in young children (1 month – 4 years). Methods: This non-randomized, open-label, and self-controlled real-world study included 105 children (1 month–4 years) with focal seizures treated with adjunctive lacosamide therapy at Children's Hospital of Chongqing Medical University. Results: (1) The 50% response rates at 3, 6, 9, and 12 months of follow-up were 58.1%, 61.0%, 57.1%, and 56.2%, while the seizure-free rates were 27.6%, 34.3%, 32.4%, and 37.1%, respectively. The 50% response rate of the first addition of lacosamide for focal seizures was much higher than the second and later added treatment at 3 months (p = 0.038). After 1 year of follow-up, these children showed an improvement in neurodevelopmental levels (p < 0.05). (2) Lacosamide retention rate was 72.7% (64/88) after 1 year of follow-up. Lack of efficacy and serious adverse events were independent risk factors for the lacosamide retention rate. (3) During adjunctive lacosamide therapy, 13 (12.4%) patients reported adverse events and five (4.7%) patients withdrew due to adverse events, including vomiting drowsiness, ataxia (0.94%), neck itching with eczema (0.94%), irritability (1.88%), and gastrointestinal discomfort (0.94%). Conclusion: Adjunctive lacosamide therapy was effective, safe, and well-tolerated in young Chinese children with focal seizures in this study. |
关键词 | adjunctive therapy children focal seizures lacosamide |
DOI | 10.1111/cns.14917 |
URL | 查看来源 |
收录类别 | SCIE |
语种 | 英语English |
WOS研究方向 | Neurosciences & Neurology ; Pharmacology & Pharmacy |
WOS类目 | Neurosciences ; Pharmacology & Pharmacy |
WOS记录号 | WOS:001287989100001 |
Scopus入藏号 | 2-s2.0-85200891436 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://repository.uic.edu.cn/handle/39GCC9TT/11732 |
专题 | 理工科技学院 |
通讯作者 | Hu, Yue |
作者单位 | 1.Chongqing Med Univ, Childrens Hosp,Big Data Engn Ctr, Natl Clin Res Ctr Child Hlth & Disorders,Chongqing, Dept Gastroenterol,Minist Educ,Key Lab Child Dev &, Chongqing, Peoples R China 2.Guangdong Provincial Key Laboratory of Interdisciplinary Research and Application for Data Science,BNU-HKBU United International College,Zhuhai,China |
推荐引用方式 GB/T 7714 | Yang, Lu,Liu, Yuhang,Deng, Yuet al. Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real-world study[J]. CNS Neuroscience and Therapeutics, 2024, 30(8). |
APA | Yang, Lu., Liu, Yuhang., Deng, Yu., Peng, Xiaoling., Hu, Qiao., .. & Hu, Yue. (2024). Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real-world study. CNS Neuroscience and Therapeutics, 30(8). |
MLA | Yang, Lu,et al."Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real-world study". CNS Neuroscience and Therapeutics 30.8(2024). |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
查看访问统计 |
谷歌学术 |
谷歌学术中相似的文章 |
[Yang, Lu]的文章 |
[Liu, Yuhang]的文章 |
[Deng, Yu]的文章 |
百度学术 |
百度学术中相似的文章 |
[Yang, Lu]的文章 |
[Liu, Yuhang]的文章 |
[Deng, Yu]的文章 |
必应学术 |
必应学术中相似的文章 |
[Yang, Lu]的文章 |
[Liu, Yuhang]的文章 |
[Deng, Yu]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论